Clinical Trials Directory

Trials / Completed

CompletedNCT04069416

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria in High Prevalence Young HCC Patients Country.

Status
Completed
Phase
Study type
Observational
Enrollment
241 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The present study aims to evaluate the impact of expanding criteria beyond Milan on tumor recurrence and patient survival that will help identify the best selection criteria for HCC transplanted patients.

Detailed description

Introduction: HEPATOCELLULAR CARCINOMA (HCC) is the second leading cause of cancer mortality worldwide. Living donor liver transplantation (LDLT) for HCC patients has emerged as a rewarding therapy for a cure and a successful alternative where a Deceased donor liver transplantation (DDLT) program is lacking. Therefore, trials for careful expansion to Milan criteria have been adopted. Aim of the study: To evaluate the impact of expanding criteria beyond Milan on tumor recurrence and patient survival that will help identify the best selection criteria for HCC transplanted patients

Conditions

Interventions

TypeNameDescription
PROCEDUREliving donor liver transplantationliver graft from a living donor

Timeline

Start date
2004-01-01
Primary completion
2015-12-01
Completion
2019-01-01
First posted
2019-08-28
Last updated
2019-08-28

Source: ClinicalTrials.gov record NCT04069416. Inclusion in this directory is not an endorsement.